News
Feed
Events
Feed
News
+ Events
Feed

Vita 34 AG

  • ISIN DE000A0BL849
  • Country Deutschland

Latest News

7 October 2024

15:01 Voting Rights Announcements DE

Vita 34 AG

Voting Rights Announcements
DE

 

14:49 Voting Rights Announcements DE

Vita 34 AG

Voting Rights Announcements
DE

 

30 August 2024

07:00 Corporate

Vita 34 AG

Corporate

Vita 34 continues positive trend in the first half of 2024 and once again significantly increases operating cash flow

22 August 2024

14:44 Advance Financial Reports

Vita 34 AG

Advance Financial Reports

 

9 August 2024

17:04 Ad-hoc

Vita 34 AG

Ad-hoc

Subsidiaries of Vita 34 reach agreement with US licensor

1 August 2024

12:39 Corporate

Vita 34 AG

Corporate

Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG

31 May 2024

08:33 Corporate

Vita 34 AG

Corporate

Vita 34 significantly increases earnings and operating cash flow in the first quarter

30 April 2024

22:51 Corporate

Vita 34 AG

Corporate

Vita 34 returns to growth path in 2023

25 April 2024

15:03 Advance Financial Reports

Vita 34 AG

Advance Financial Reports

 

19 April 2024

12:28 Ad-hoc

Vita 34 AG

Ad-hoc

Vita 34 closes 2023 with significantly better results than expected based on preliminary figures

31 January 2024

17:03 Ad-hoc

Vita 34 AG

Ad-hoc

Vita 34 publishes preliminary figures on the course of business in 2023

2 January 2024

12:13 Corporate

Vita 34 AG

Corporate

Vita 34 downsizes Management Board until further notice

11 December 2023

11:18 Directors’ Dealings

Vita 34 AG

Directors’ Dealings

Vita 34 AG: AOC Health GmbH, Acquisition of shares as part of a capital increase

11:05 Directors’ Dealings

Vita 34 AG

Directors’ Dealings

Vita 34 AG: Jakub Julian Baran, buy

7 December 2023

15:28 Total Voting Rights

Vita 34 AG

Total Voting Rights

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

27 November 2023

11:37 Ad-hoc

Vita 34 AG

Ad-hoc

Vita 34 AG: resolves on cash capital increase under exclusion of subscription rights in the amount of up to 10% of the share capital, commitments from investors

24 November 2023

07:00 Corporate

Vita 34 AG

Corporate

Vita 34 increases revenue and earnings in Q3 2023 and further stabilizes business development

17 November 2023

15:30 Advance Financial Reports

Vita 34 AG

Advance Financial Reports

 

10 November 2023

14:57 Ad-hoc

Vita 34 AG

Ad-hoc

Internal investigation by Vita 34 AG reveals irregularities related to a limited number of biological samples at one of its subsidiaries regarding compliance with medical law requirements

27 September 2023

19:21 Ad-hoc

Vita 34 AG

Ad-hoc

Vita 34 AG: A subsidiary of Vita 34, FamiCordTx, will file a lawsuit against a US licensor

5 September 2023

11:22 Voting Rights Announcements DE

Vita 34 AG

Voting Rights Announcements
DE

 

31 August 2023

10:30 Corporate

Vita 34 AG

Corporate

Vita 34 stabilizes business development in the second quarter and noticeably improves earnings

24 August 2023

16:08 Advance Financial Reports

Vita 34 AG

Advance Financial Reports

 

31 May 2023

08:00 Corporate

Vita 34 AG

Corporate

Vita 34 successfully implements price increases in first quarter of 2023 in generally weak market environment

24 May 2023

15:18 Advance Financial Reports

Vita 34 AG

Advance Financial Reports

 

12 May 2023

09:10 Corporate

Vita 34 AG

Corporate

Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate

30 April 2023

12:00 Corporate

Vita 34 AG

Corporate

Development of Vita 34 AG in 2022 stressed by weakened consumption power of consumers along with one-off effects

25 April 2023

18:43 Ad-hoc

Vita 34 AG

Ad-hoc

Vita 34 AG publishes outlook for the 2023 financial year

21 April 2023

11:11 Advance Financial Reports

Vita 34 AG

Advance Financial Reports

 

6 April 2023

20:39 Ad-hoc

Vita 34 AG

Ad-hoc

2022 annual result of Vita 34 AG significantly influenced by impairment of goodwill

Upcoming Events

22

Nov 24

Vita 34 AG

Publication quarterly statement (call-date Q3)

IR contact

Vita 34 AG

Vita 34 AG

Deutscher Platz 5
04103 Leipzig
Deutschland
Tel.: +49 (0)341 48792-40
Fax: +49 (0)341 48792-39
Mail:ir@vita34.de